期刊文献+

中山大学孙逸仙纪念医院2013年阿司匹林门诊超说明书用药回顾性调查 被引量:4

Off-label Use of Aspirin in Outpatients of Sun Yat-sen Memorial Hospital in 2013: A Retrospective Survey
原文传递
导出
摘要 目的了解中山大学孙逸仙纪念医院门诊阿司匹林超说明书用药现状,为制订超说明书用药政策提供基线数据。方法采用分层随机抽样的方法,收集2013年门诊阿司匹林的处方数据,采用卡方检验比较阿司匹林超说明书用药不同类型间发生率,采用logistic回归模型分析阿司匹林各类超说明书用药发生的影响因素。结果共抽取门急诊阿司匹林处方5 023张,超说明书用药率达17.7%。超说明书超适应证使用高达94.38%,超适应证前3分别为:复发性流产、不孕症和系统性红斑狼疮。年龄、性别、药品规格、处方开具科室均是超说明书用药风险因素。结论中山大学孙逸仙纪念医院2013年门诊阿司匹林超说明书用药情况普遍,以妇产科和生殖中心女性生殖超说明书用药现象最显著,提示仍需促进阿司匹林在生殖方面的临床试验以提供更多的用药证据,保障阿司匹林的用药安全和规避相关医疗风险。 Objective To understand the situation of off-label use of aspirin among outpatients in Sun Yat- sen Memorial Hospital, so as to provide baseline data for developing off-label drug use policy. Methods A stratified random sampling method was used to collected prescription data of aspirin among outpatients in 2013. The incidence rates between different types of off-label use of aspirin were determined by chi-square test, and the influence factors of off-label drug use were analyzed by logistic regression model. Results A total of 5 023 prescriptions with aspirin were collected and analyzed, with incidence rate of off-label use up to 17.7%. The major category of off-label use was no indication (94.38%). The top 3 no indications were recurrent abortion, infertility and systemic lupus erythematosus. Drug specification, gender, age and prescribed department were the risk factors of off-label use. Conclusion Aspirin off-label use is common among outpatients in Sun Yat-sen Memorial Hospital in 2013, especially in obstetrics and gynecology department and assisted reproductive center. The results suggest that more clinical studies about aspirin for reproduction are needed to provide more evidence of drug use, so as to potential medical risk, ensure the safety of drug use in special populations and avoid potential medical risk.
出处 《中国循证医学杂志》 CSCD 2015年第12期1365-1371,共7页 Chinese Journal of Evidence-based Medicine
关键词 阿司匹林 超说明书用药 门诊 危险因素分析 安全用药 Aspirin Off-label use Outpatient Risk factors analysis Drug safety
  • 相关文献

参考文献12

  • 1广东省药学会.药品未注册用法专家共识.2010年3月18日.
  • 2Thorat MA, Cuzick L Role of aspirin in cancer prevention. Curr Oncol Rep, 2013, 15(6): 533-540.
  • 3Patrono C, Garcia Rodriguez LA, Landolfi R, et al. Low-dose aspirin for the prevention of atherothrombosis. N Engl J ivied, 2005, 353(22): 2373-2383.
  • 4Garcia Rodriguez LA, Hernandez-Diaz S. Risk of uncomplicated peptic ulcer among users of aspirin and non-aspirin non-steroidal anti-inflammatory drugs. Am J Epidemiol, 2004, 159(1 ): 23-31.
  • 5Cuzick J, Thorat MA, Bosetti C, et al. Estimates of benefits and harms of prophylactic use of aspirin in the general population. Ann Oncol, 2014, 26(1): 47-57.
  • 6赵敏,常才.阿司匹林在妇产科的应用[J].国外医学(妇产科学分册),2007,34(6):391-394. 被引量:20
  • 7Backos M, Rai R, Baxter N, et al. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Br] Obstet Gynaecol, 1999, 106(2): 102-107.
  • 8Rubinstein M, Marazzi A, Polakde de Fried E. Low-dose aspirin treatment improves ovarian responsiveness, uterineand ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double blind placebo controlled assay. Fertil Steril, 1999, 71(5): 825-829.
  • 9McCowan LM, Harding J, RobertsA, et al. Administration of low- dose aspirin to mothers with small for gestational age fetuses and abnormal umbilical Doppler studies to increase birth weight: a randomized double-blind controlled trial. Br I Obstet Gynaecol, 1999, 106(7): 647-651.
  • 10Sibai BM, Caritis SN, Thom E, et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl ] Med, 1993, 329(17): 1213-1218.

二级参考文献20

  • 1Chiaffarino F, Parazzini F, Paladini D, et al. A small randomised trial of low-dose aspirin in women at high risk of pre-eelampsia[ J]. Eur J Obstet Gynecol Reprod Biol, 2004, 112 (2): 142-144.
  • 2Tarim E, Bal N, Kilicdag E, et al. Effects of aspirin on placenta and perinatal outcomes in patients with poor obstetric history [ J]. Arch Gyneeol Obstet, 2006, 274(4): 209-214.
  • 3Kalinka J, Gottwald L, Nowakowski M, et al. The impact of lowdose aspirin therapy on umbilical and middle cerebral artery blood flow in pregnancy complicated by idiopathic intrauterine growth restriction[J]. Ginekol Pol, 2004, 75(4): 254-260.
  • 4Boog G, Le VaiUant C, Alnoukari F, et al. Combining corticosteroid and aspirin for the prevention of recurrent villitis or intervillositis of unknown etiology[J]. J Gynecol Obstet Biol Reprod (Paris), 2006, 35(4): 396-404.
  • 5Noble LS, Kutteh WH, Lashey N, et al. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecularweight heparin versus unfractionated heparin [J]. Fertil Steril, 2005, 83(3): 684-690.
  • 6Spitzer KA, Murphy K, Crowther M, et al. Postpartum management of women at increased risk of thrombosis-results of a Canadian pilot survey [ J ]. J Rheumatol, 2006, 33 ( 11 ): 2222-2226.
  • 7Pacealin M, Manic H, Bouehe G, et al. Antiphospholipid syndrome in patients with retinal venous occlusion [J]. Thromb Res, 2006,117(4):365-369.
  • 8Finazzi G, Marchioli R, Brancaccio V, et al. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS) [J]. J Thromb Haemost, 2005, 3(5): 848-853.
  • 9Tzafettas J, Petropoulos P, Psarra A, et al. Early antiplatelet and antithrombotic therapy in patients with a history of recurrent miscarriages of known and unknown aetiology [J]. Eur J Obstet Gynecol Reprod Biol, 2005, 120( 1 ): 22-26.
  • 10Waldenstrom U, Hellberg D, Nilsson S. Low-dose aspirin in a short regimen as standard treatment in in vitro fertilization: a randomized, prospective study[J]. Fertil Steril, 2004, 81 (6): 1560-1564.

共引文献23

同被引文献31

  • 1赵敏,常才.阿司匹林在妇产科的应用[J].国外医学(妇产科学分册),2007,34(6):391-394. 被引量:20
  • 2Jack DB. One hundred years of aspirin[J]. Lancet, 1997, 350(9075): 437-439.
  • 3Patrono C, Rocca B. Aspirin: promise and resistance in the new millennium[J]. Arterioscler Thromb Vase Biol, 2008, 28(3): s25-s32.
  • 4Thun M J, Henley S J, Patrono C. Nonsteroidal anti- inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues[J]. J Natl Cancer Inst, 2002, 94(4): 252-266.
  • 5Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of 5 randomised trials[J]. Lancet, 2010, 376(9754): 1741-1750.
  • 6Cuzick J, Otto F, Baron JA, et al. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement[J]. Lancet Oncol, 2009, 10(5): 501-507.
  • 7Caitis S, Sibai B, Hauth J, et al. Low-dose aspirin to preventpreeclampsia in women at high risk[J]. N Engl J Med, 1998, 3380 1): 701-705.
  • 8Harold J. DeMonaco H J, Ali A, et al. The major role of clinicians in the discovery of off-label drug therapies[J]. Phammcotherapy, 2006, 26(3): 323-332.
  • 9Czaja AS, Valuck R. Off-label antidepressant use in children and adolescents compared with young adults: extent and level of evidence[J]. Pharmacoepidemiol Drug Saf, 2012, 21(9): 997-1004.
  • 10Kaandorp SP, Goddijn M, van der Post JA, et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage[J]. N Engl J Med, 2010, 362(17): 1586-1596.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部